How do you pay?

How to pay the least

Ask for the cash price

Tascenso ODT

We didn’t find one.

  1. Ask your pharmacy for Tascenso ODT’s cash price, and one or two other pharmacies too.
  2. Tascenso ODT’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameTascenso ODT
Authorized genericfingolimod
Regular genericfingolimod
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Tascenso ODT?
The original
–
–

Brand nameThe maker’s card

Cycle Vita Co-pay Assistance Program

Savings card from Cycle Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on tascenso.com 

See the offer on tascenso.com

In the maker’s words

“If you are commercially insured and eligible you may pay as little as $0.”

From the maker’s offer on tascenso.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Tascenso ODT itself, from the same company, sold without the brand name, and usually for less. For now Tascenso ODT is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TASCENSO ODT is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.

Source: the FDA label for Tascenso ODT (Cycle Pharmaceuticals Ltd), January 20, 2026. Full label on DailyMed 

Good to know